Quantcast

Latest Statin Stories

2014-03-17 08:30:17

Study Meets Primary Endpoint of LDL Cholesterol Reduction THOUSAND OAKS, Calif., March 17, 2014 /PRNewswire/ -- Amgen (NASDAQ:AMGN) today announced that the Phase 3 TESLA (Trial Evaluating PCSK9 Antibody in Subjects with LDL Receptor Abnormalities) trial evaluating evolocumab met its primary endpoint of the percent reduction from baseline at week 12 in low-density lipoprotein cholesterol (LDL-C). The percent reduction in LDL-C, or "bad" cholesterol, was clinically meaningful and statistically...

2014-03-14 23:01:01

The Firm is investigating Lipitor Lawsuits on behalf of patients who allegedly developed Type 2 diabetes due to treatment with the cholesterol-lowering statin. New York, New York (PRWEB) March 14, 2014 Lipitor lawsuits (http://www.thelipitorlawsuit.com/ ) continue to mount in the multidistrict litigation now underway in U.S. District Court, District of South Carolina, Bernstein Liebhard LLP reports. According to an updated docket report issued by the U.S. Judicial Panel on Multidistrict...

2014-03-11 00:22:36

When combined with conventional blood clot prevention therapies, statins lowered the occurrence of venous thromboembolic (VTE) events by 48 percent NEW ORLEANS, March 11, 2014 /PRNewswire-USNewswire/ -- Statins have long been known to lower cholesterol and, more recently, to decrease the risk of deep vein thrombosis (blood clots) in healthy, non-surgical patients. New, first-of-its-kind research presented today at the 2014 Annual Meeting of the American Academy of Orthopaedic...

2014-03-08 23:01:36

The Firm is evaluating Lipitor lawsuits on behalf of plaintiffs who allegedly developed new-onset Type 2 diabetes due to their use of Lipitor. New York, NY (PRWEB) March 08, 2014 Lipitor lawsuits (http://www.thelipitorlawsuit.com/) that claim the statin drug caused patients to develop new-onset Type 2 diabetes continue to mount in courts around the country, Bernstein Liebhard LLP reports. According to court documents, four women recently filed claims in U.S. District Court, Northern...

2014-03-06 08:30:13

- A significant addition that complements the company's innovative suite of diagnostics and services, Boston Heart's MPO is easy for clinicians to use and FDA-cleared. FRAMINGHAM, Mass., March 6, 2014 /PRNewswire/ -- Boston Heart Diagnostics Corporation, a pioneer in integrating next-generation diagnostics into personalized nutrition and lifestyle programs for patients with or at risk for heart disease, announced the commercial launch of an FDA-cleared MPO (myeloperoxidase) test, a...

That Angry Outburst May Lead To Heart Attack or Stroke
2014-03-04 10:02:56

Lawrence LeBlond for redOrbit.com - Your Universe Online It is known that bouts of anger can raise a person’s stress level and continued stress can lead to other health-related issues such as heart attack and stroke. But a new look at several studies has led researchers to the determination that anger itself can cause stroke or heart attack within a few hours of an outburst. Dr Murray Mittleman, of Harvard School of Public Health, and colleagues found that people who lose their temper...

2014-03-03 23:01:45

Kyowa Hakko USA announces that Pantesin is a comprehensive and safe dietary supplement that supports healthy cholesterol levels. New York, NY (PRWEB) March 03, 2014 A recently published study in Vascular Health and Risk Management showed that Pantesin® Pantethine was effective in lowering cardiovascular risk markers in study participants with low to moderate risk factors who were eligible for statin therapy. Specifically when compared to placebo, Pantesin showed significant changes...

2014-03-03 23:01:36

The Firm is investigating Lipitor lawsuits on behalf of individuals who allegedly developed new-onset Type 2 diabetes due to their use of Lipitor. New York, New York (PRWEB) March 03, 2014 As Lipitor lawsuits (http://www.thelipitorlawsuit.com/ ) alleging use of the popular cholesterol-lowering medication continue to move forward in federal court, Bernstein Liebhard LLP notes that Pfizer, Inc. recently launched a clinical trial of an over-the-counter (OTC) version of Lipitor. According to...

2014-02-28 23:26:13

Icahn School of Medicine at Mount Sinai study suggests early-stage atherosclerosis is reversible, and identifies new genetic targets for fighting advanced atherosclerosis New York, NY (PRWEB) February 28, 2014 Research at Icahn School of Medicine at Mount Sinai has led to important new discoveries about the process behind regression of atherosclerosis, the main underlying cause of heart attack and stroke. In the paper published today in PLoS Genetics, scientists from Mount Sinai and the...

2014-02-24 23:02:53

USApple Shares Research on the Health Benefits of an Apple (or Two) a Day During American Heart Health Month Vienna, VA (PRWEB) February 24, 2014 An apple (or two) a day keeps not only the doctor – but the cardiologist – away. USApple is reminding people that eating apples can be one of the most convenient and accessible ways to fight many of the factors that contribute to heart disease, the leading cause of death in the United States. Here are four reasons why:...


Word of the Day
drawcansir
  • A blustering, bullying fellow; a pot-valiant braggart; a bully.
This word is named for Draw-Can-Sir, a character in George Villiers' 17th century play The Rehearsal.
Related